Christophe Ravoet
Christophe Ravoet publishes mostly in Hematology, Genetics and Oncology, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Hemoglobinopathies and Related Disorders.
- World rank
- #2,151,863 of 7,710,434 ranked researchers
- Rank in Belgium
- #19,715 of 67,186
- Works
- 61
- Citations
- 2.3k
- Citations per work
- 38.5
What does Christophe Ravoet research?
Christophe Ravoet's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3658.8%
- Medicine3658.8%
- Everything else1728.3%
- Life Sciences812.9%
- 1Hematology24% of their works
- 2Genetics18% of their works
- 3Oncology10% of their works
- 4Molecular Biology9% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Immunology4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Neutropenia and Cancer Infections
- Hematopoietic Stem Cell Transplantation
Which keywords describe Christophe Ravoet's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations and JAK2 Mutation.
- Bone Marrow Niche
- Antimicrobial Agents
- Diagnosis Criteria
- Classification
- Sickle-cell Disease
- JAK2 Mutation
- Chronic Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Rituximab
- Genomic Aberrations
- Myelofibrosis
- Thalassemia
- Lymphoma
- International Myeloma Working Group
- Febrile Neutropenia
- Graft-versus-Host Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors312 topics
- Hematopoietic Stem Cells262 topics
- AML211 topic
- Acute Myeloid Leukemia211 topic
- Rituximab182 topics
- Chronic Lymphocytic Leukemia101 topic
- Genomic Aberrations101 topic
- JAK2 Mutation91 topic
- Myelofibrosis91 topic
- Sickle-cell Disease91 topic
- Thalassemia91 topic
- Classification81 topic
- Lymphoma81 topic
- Diagnosis Criteria71 topic
- International Myeloma Working Group71 topic
- Antimicrobial Agents61 topic
- Febrile Neutropenia61 topic
- Bone Marrow Niche51 topic
- Graft-versus-Host Disease51 topic
Where does Christophe Ravoet work?
Christophe Ravoet's main affiliation in the publication record is Hôpital de Jolimont, Belgium.
How many publications and citations does Christophe Ravoet have?
OpenAlex counts 61 works and 2,347 citations for Christophe Ravoet, an h-index of 19, ranking #2,151,863 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christophe Ravoet. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.